Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial outer membrane lipopolysaccharide layer** (LPS layer) is the defining component of the outer membrane of Gram-negative bacteria and is critical for their structure, pathogenicity, and survivability. The LPS layer is composed of large glycolipid macromolecules consisting of three parts: lipid A (the membrane anchor and main immunostimulatory moiety), a core oligosaccharide, and an O-antigen polysaccharide (which determines serotype and immune recognition)[4][5][6]. The LPS layer acts as a strong permeability barrier, preventing entry of toxic molecules and many antibiotics, and is highly resilient due to tight molecular packing and stabilization by divalent cations[2][4][7]. LPS is the primary trigger of innate immune responses in the host and is responsible for the toxicity of Gram-negative septicemia (endotoxin shock)[3][5]. While the LPS layer itself is not a single "target" in the traditional sense of a protein or receptor, it is indispensable for bacterial viability and serves as a primary target of certain antibiotics (notably polymyxins), and is the basis for numerous vaccine and diagnostic approaches[2][5][6]. Drugs may interact directly with LPS to disrupt membrane integrity, or indirectly by inhibiting its biosynthesis or transport to the outer membrane (via the LptABCDFEG protein complex)[1][2]. LPS modifications are a frequent resistance mechanism, and therapeutic strategies targeting the LPS layer face the challenge of balancing antimicrobial efficacy with avoidance of immunopathologic host responses[2][5][7].
Disruption of outer membrane integrity (permeabilization of LPS by polymyxins) Inhibition of LPS transport or insertion (Lpt inhibitors) Neutralization of endotoxin (LPS-binding molecules)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial outer membrane lipopolysaccharide layer (LPS layer).